Mario L. Squadrito

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Targeting immune heterogeneity in liver metastases through in vivo genetic engineering.

Targeting immune heterogeneity in liver metastases through in vivo genetic engineering.

Journal: Seminars in immunology
Published: October 01, 2025

A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice.

A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice.

Journal: Science translational medicine
Published: July 02, 2025

Ad-justing macrophages for cancer immunotherapy.

Ad-justing macrophages for cancer immunotherapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 26, 2025

Reprogramming liver metastasis-associated macrophages toward an anti-tumoral phenotype through enforced miR-342 expression.

Reprogramming liver metastasis-associated macrophages toward an anti-tumoral phenotype through enforced miR-342 expression.

Journal: Cell reports
Published: August 13, 2024

In vivo armed macrophages curb liver metastasis through tumor-reactive T-cell rejuvenation.

In vivo armed macrophages curb liver metastasis through tumor-reactive T-cell rejuvenation.

Journal: Nature communications
Published: July 19, 2024

VisualZoneR: A computational protocol to identify compartmental zones from single-cell spatial transcriptomics using R.

VisualZoneR: A computational protocol to identify compartmental zones from single-cell spatial transcriptomics using R.

Journal: STAR protocols
Published: February 23, 2024

Harnessing lentiviral vectors for in vivo gene therapy of liver metastases.

Harnessing lentiviral vectors for in vivo gene therapy of liver metastases.

Journal: Clinical and translational medicine
Published: December 21, 2023

In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases.

In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases.

Journal: Cancer cell
Published: February 17, 2023

VEGF-C-expressing TAMs rewire the metastatic fate of breast cancer cells.

VEGF-C-expressing TAMs rewire the metastatic fate of breast cancer cells.

Journal: Cell reports
Published: December 16, 2022

TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells.

TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells.

Journal: Science immunology
Published: August 19, 2022

Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth.

Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth.

Journal: Nature cardiovascular research
Published: May 23, 2022

MNK2 governs the macrophage antiinflammatory phenotype.

MNK2 governs the macrophage antiinflammatory phenotype.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 20, 2020
Showing 1-12 of 36

Last Updated: 09/26/2026